Glassy cell carcinoma of the cervix revisited

Gynecologic Oncology

Volumn 85, Issue 2, 2002, Pages 274-277

  Gray, Heidi J ^a   Garcia, Rochelle ^a   Tamimi, Hisham K ^a   Koh, Wui Jin ^a   Goff, Barbara A ^a   Greer, Benjamin E ^a   Paley, Pamela J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; UTERINE CERVIX GLASSY CELL CARCINOMA;

EID: 0036095857     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6523     Document Type: Article

References (10)

1. Incidence, histology and response to radiation of mixed carcinomas (adenocanthomas) of the uterine cervix
2. Glassy cell carcinoma of the uterine cervix - An ultrastructure study and review
3. Glassy cell carcinoma of the cervix
4. Glassy cell cervical carcinoma
5. Glassy cell carcinoma of the cervix
6. Glassy cell carcinoma of the cervix
7. Glassy cell carcinoma of the cervix redefined
8. Glassy cell carcinoma of the cervix - A bimodal treatment strategy
9. Adjuvant therapy for high-risk, early stage cervical cancer
10. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy - A Gynecologic Oncology Group study